Auxilium's Peyronie’s disease treatment approved by FDA The U.S. FDA approved a new use for Xiaflex as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie’s disease. Xiaflex is the first FDA-approved non-surgical treatment option for men with this condition, who have a plaque in the penis that results in a curvature deformity of at least 30 degrees upon erection. Xiaflex is marketed by Auxilium Pharmaceuticals.
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.